← The Wire
AQSTNasdaq
Aquestive Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1398733
Aquestive develops and manufactures innovative medicines using proprietary delivery technologies for improved patient outcomes
$523M
Market cap
$4.16
Last close
-5.2%
1D
-11.9%
5D
3.3M
Volume
Price · last 39 sessions-1.4%
May 4L $3.91 · H $5.03Jun 29
254
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 10, 202610-Q10-QMay 13, 20268-KMaterial Agreement · Agreement TerminatedMay 13, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KReg FD DisclosureMar 30, 20268-KExecutive Change · Reg FD DisclosureMar 20, 202610-K10-KMar 4, 20268-KMaterial Agreement · Results of OperationsMar 4, 20268-KReg FD DisclosureFeb 26, 20268-KReg FD DisclosureFeb 2, 20268-KCompany UpdateJan 9, 20268-KReg FD DisclosureNov 6, 202510-Q10-QNov 5, 20258-KResults of Operations · Reg FD DisclosureNov 5, 20258-KCompany UpdateOct 8, 20258-KReg FD DisclosureOct 1, 20258-KReg FD DisclosureSep 8, 20258-KReg FD DisclosureSep 4, 20258-KMaterial Agreement · Reg FD DisclosureAug 15, 2025424B5424B5Aug 14, 20258-KMaterial Agreement · Reg FD DisclosureAug 14, 202510-Q10-QAug 11, 20258-KResults of Operations · Reg FD DisclosureAug 11, 20258-KCompany UpdateJul 15, 20258-KReg FD DisclosureJun 16, 20258-KShareholder VoteJun 11, 20258-KReg FD DisclosureJun 2, 202510-Q10-QMay 12, 20258-KResults of Operations · Reg FD DisclosureMay 12, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KReg FD DisclosureApr 1, 20258-KReg FD DisclosureMar 10, 202510-K10-KMar 5, 20258-KResults of Operations · Reg FD DisclosureMar 5, 20258-KCompany UpdateFeb 12, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KCompany UpdateDec 19, 20248-KReg FD Disclosure · Company UpdateDec 2, 2024SC 13GSC 13GNov 8, 20248-KExecutive ChangeNov 7, 20248-KReg FD DisclosureNov 6, 202410-Q10-QNov 4, 20248-KResults of Operations · Reg FD DisclosureNov 4, 20248-KCompany UpdateOct 25, 20248-KReg FD Disclosure · Company UpdateOct 24, 2024SC 13GSC 13GOct 22, 20248-KBylaw AmendmentOct 16, 20248-KReg FD Disclosure · Company UpdateSep 27, 20248-KReg FD DisclosureSep 9, 20248-KCompany UpdateAug 14, 202410-Q10-QAug 6, 20248-KResults of Operations · Reg FD DisclosureAug 6, 20248-KReg FD Disclosure · Company UpdateJul 25, 20248-KShareholder VoteJun 21, 20248-KReg FD DisclosureJun 7, 20248-KExecutive ChangeJun 6, 20248-KReg FD DisclosureMay 8, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 7, 20248-KCompany UpdateApr 29, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KCompany UpdateApr 22, 2024SC 13GSC 13GApr 1, 20248-KExecutive ChangeApr 1, 20248-KMaterial Agreement · Company UpdateMar 21, 2024424B5424B5Mar 21, 2024424B5424B5Mar 19, 20248-KCompany UpdateMar 15, 202410-K10-KMar 5, 20248-KResults of Operations · Reg FD DisclosureMar 5, 2024SC 13GSC 13GFeb 14, 20248-KReg FD DisclosureDec 8, 20238-KCompany UpdateDec 5, 20238-KReg FD DisclosureNov 8, 202310-Q10-QNov 6, 20238-KResults of Operations · Reg FD DisclosureNov 6, 20238-KMaterial Agreement · Agreement TerminatedNov 2, 2023
Insider Activity
In the 90 days to Mar 10, 2026: 7 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Barber DanielPresident and CEO | Sell | 180,677 | $4.17 | $753K |
| Mar 10, 2026 | Toth A Ernest JrChief Financial Officer | Sell | 58,254 | $4.17 | $243K |
| Mar 10, 2026 | Jung CassieChief Operating Officer | Sell | 45,791 | $4.17 | $191K |
| Mar 10, 2026 | Braender Lori JChief Legal Officer | Sell | 40,102 | $4.17 | $167K |
| Mar 10, 2026 | Boyd Peter E.Chief People Officer | Sell | 29,814 | $4.17 | $124K |
| Mar 10, 2026 | Cioffi MelinaSVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $106K |
| Mar 10, 2026 | Korczynski SherryChief Commercial Officer | Sell | 15,741 | $4.17 | $66K |
| Oct 15, 2025 | Jung CassieChief Operating Officer | Sell | 67,575 | $7.01 | $474K |
| Oct 15, 2025 | Kraus Carl NChief Medical Officer | Sell | 20,272 | $7.00 | $142K |
| Oct 15, 2025 | Boyd Peter E.See Remarks | Sell | 10,000 | $7.00 | $70K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance